PRGO / Perrigo Company plc - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

List of Guarantor Subsidiaries

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of June 28, 2025, the obligors under (i) the 5.

Amendment No. 1 to Employment Agreement, dated as of June 25, 2025, by and between Perrigo Pharma International D.A.C and Roberto Khoury (filed herewith).

a101-ppidacamendmentxno Private & Confidential June 25, 2025 Roberto Khoury Amendment No.

Employment Separation and Severance Letter Agreement, dated as of June 25, 2025, by and between the Company and Catherine Schmelter (filed herewith).

a102-fullyexecutedschmel Initials June 25 2025 PERSONAL AND CONFIDENTIAL Catherine Schmelter RE: Employment Separation and Severance Perrigo Company Confidential Waiver and Release Agreement for U.

Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations Company Advanced its ‘Three-S’ Plan (Stabilize, Streamline, and Strengthen) with Recently Announced Agreement to Sell Dermacosmetics Business, Scaling of Global Operatin

EXHIBIT 99.1 Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations Company Advanced its ‘Three-S’ Plan (Stabilize, Streamline, and Strengthen) with Recently Announced Agreement to Sell Dermacosmetics Business, Scaling of Global Operating Growth Model, and Upgraded Brand Building Capabilities that are Delivering Results Solid Execution Amid Challenging Market Consumption

Fixed Term Offer Letter Agreement, dated as of June 2, 2025, by and between the Company and Ronald Janish (filed herewith).

a104-ronjanishusfixedter June 2, 2025 Ron Janish Dear Ron, You have been a valued member of the Perrigo leadership team for many years.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2025 Perrigo Company pl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: June 28, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: June 28, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to Commission file number 001-36353 Perrigo Company plc (Ex

Perrigo Announces Proposed Divestiture of Dermacosmetics Business for up to €327 Million Proposed Divestiture Advances Company’s ‘Three-S’ Plan to Streamline its Portfolio and Strengthen Focus on its ‘High-Grow’ Brands Total Consideration of Up to €3

Exhibit 99.1 Perrigo Announces Proposed Divestiture of Dermacosmetics Business for up to €327 Million Proposed Divestiture Advances Company’s ‘Three-S’ Plan to Streamline its Portfolio and Strengthen Focus on its ‘High-Grow’ Brands Total Consideration of Up to €327 Million, Consisting of €300 Million in Upfront Cash and Up to €27 Million in Potential Future Milestone Payments Expected Net Proceeds

Master Sale and Purchase Agreement, dated as of July 13, 2025, by and between Perrigo Company plc and Kairos Bidco AB.

Exhibit 2.1 13 July 2025 Perrigo Company plc (as Seller) and Kairos Bidco AB (as Purchaser) MASTER SALE AND PURCHASE AGREEMENT for the sale and purchase of certain parts of Perrigo’s European skin care business CERTAIN CONFIDENTIAL INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL CONTE

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance Company to Scale and Optimize Global Category-Led, Market Activation Growth Model Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), A

EX-99.1 Exhibit 99.1 Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance Company to Scale and Optimize Global Category-Led, Market Activation Growth Model Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), Appointed to New Position of EVP & Chief Commercial Officer to Lead Global Market Activation Triona Schmelter, EVP & President Con

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2025 Perrigo Company plc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2024 OR [ ] TRANSITION REPORT PURSUANT TO SECT

Compromise Waiver Agreement, dated as of June 2, 2025, between Perrigo Corporation DAC and Ronald Janish (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 4, 2025).

EX-10.1 Exhibit 10.1 WITHOUT PREJUDICE AND SUBJECT TO CONTRACT/CONTRACT DENIED COMPROMISE WAIVER AGREEMENT AGREEMENT DATED 2 June 2025 between: (1) Perrigo Corporation DAC whose registered address is at The Sharp Building, Hogan Place, Dublin 2 (the Company); and (2) Ronald Janish [Intentionally Omitted] (the Employee) COLLECTIVELY: the Parties WHEREAS: (A) The Employee has been employed by the Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 Perrigo Company plc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpo

Perrigo Announces Global Operations and Supply Chain Leadership Transition Ron Janish, EVP Global Operations and Supply Chain, to Retire Industry Veteran, Matt Winterman, Appointed EVP Product Supply, Operations Strategy & Transformation Officer

Exhibit 99.1 Perrigo Announces Global Operations and Supply Chain Leadership Transition Ron Janish, EVP Global Operations and Supply Chain, to Retire Industry Veteran, Matt Winterman, Appointed EVP Product Supply, Operations Strategy & Transformation Officer Dublin, Ireland – June 4, 2025 – Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PERRIGO COMPANY PLC (Exact name of registrant as specified in its charter) Ireland 001-36353 Not Applicable (State or other jurisdiction (Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PERRIGO COMPANY PLC (Exact name of registrant as specified in its charter) Ireland 001-36353 Not Applicable (State or other jurisdiction (Commission (IRS Employer of incorporation or organization) File Number) Identification No.) The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74

orms of rTSR Performance-Based Restricted Stock Unit Award Agreement (filed herewith).

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Performance-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

List of Guarantor Subsidiaries

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of March 29, 2025, the obligors under (i) the 5.

ased Restricted Stock Unit Award Agreement (filed herewith).

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (SERVICE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Service-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Perrigo Company plc (Exact Name of Registrant as Specified in its Charter ) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Ordinary shares, par value €0.

Memorandum and Articles of Association of Perrigo Company plc, as amended and restated (filed herewith).

MEMORANDUM AND ARTICLES OF ASSOCIATION OF PERRIGO COMPANY PUBLIC LIMITED COMPANY 1 2 Companies Act 2014 A PUBLIC COMPANY LIMITED BY SHARES MEMORANDUM OF ASSOCIATION -of- PERRIGO COMPANY PUBLIC LIMITED COMPANY (as amended by special resolutions passed up to 1 May 2025) 1.

Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations Advancing 'Three-S' Plan to Stabilize, Streamline and Strengthen Perrigo, which was Detailed at February 2025 Investor Day Delivered Strong First Quarter 2025 Adjusted EP

EXHIBIT 99.1 Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations Advancing 'Three-S' Plan to Stabilize, Streamline and Strengthen Perrigo, which was Detailed at February 2025 Investor Day Delivered Strong First Quarter 2025 Adjusted EPS Growth and Margin Expansion, Driven by Continuing Infant Formula Business Recovery Widening 2025 Net Sales Target Ranges, Due Primarily

As Filed with the Securities and Exchange Commission on May 7, 2025

S-8 As Filed with the Securities and Exchange Commission on May 7, 2025 Registration Statement No.

orms of OI Performance-Based Restricted Stock Unit Award Agreement (filed

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Performance-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: March 29, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 29, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 Perrigo Company plc (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

orms of Performance-Based and Service-Based Restricted Stock Unit Award Agreements for Patrick Lockwood-Tayl

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Performance-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2025 Perrigo Company plc (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

Subsidiaries of the Registrant

Exhibit 21 PERRIGO SUBSIDIARIES Name of Subsidiary State/Country of Incorporation Chefaro Ireland Designated Activity Company Ireland Elan International Services Limited Ireland Omega Teknika Designated Activity Company Ireland Perrigo Company plc Ireland Perrigo Corporation Designated Activity Company Ireland Perrigo Finance Unlimited Company Ireland Perrigo Holdings Unlimited Company Ireland Per

List of Guarantor Subsidiaries (filed herewith)

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of December 31, 2024, the obligors under (i) the 5.

Amendment No. 2 and Incremental Assumption Agreement to Credit Agreement, dated December 13, 2024, among Perrigo Investments, LLC, as borrower, Perrigo Company plc, as parent, the Guarantors, the 2024 Refinancing Term B Lenders, and JPMorgan Chase Bank, N.A., as administrative agent (filed herewith).

Execution Version This AMENDMENT NO. 2 (this “Amendment No. 2”), dated as of December 13, 2024 and entered into by and among Perrigo Investments, LLC, a Delaware limited liability company (the “Borrower”), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the “Parent”), the other Guarantors party hereto, the 2024 Refinancing Term B Lenders (as defined below) and JP

Perrigo's Clawback Policy (filed herewith).

PERRIGO COMPANY PLC COMPENSATION RECOVERY POLICY SECTION 1. POLICY The Board of Directors (the “Board”) of Perrigo Company plc (the “Company”) has adopted this Compensation Recovery Policy (this “Policy”) pursuant to Rule 10D-1 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), the Securities and Exchange Commission regulations promulgated thereunder, and applicable New Y

Insider Trading Policy (filed herewith).

POLICY ON INSIDER TRADING AND SECURITIES TRANSACTIONS Table of Contents 1. PURPOSE 1 2. SCOPE 1 3. NO TRADING OR TIPPING ON MATERIAL, NON-PUBLIC INFORMATION 2 4. “BLACKOUT” PERIODS WHEN TRADING IS PROHIBITED 2 5. WHAT TRADES ARE PROHIBITED? 3 6. ADDITIONAL PROHIBITED TRANSACTIONS 4 7. PRE-CLEARANCE OF SECURITIES TRADES 4 8. EXCEPTION FOR APPROVED 10B5-1 PLANS 4 9. SECTION 16 OBLIGATIONS AND RESTRI

Description of the Company’s Securities (filed herewith).

DESCRIPTION OF ORDINARY SHARES The summary of the general terms and provisions of the shares of Perrigo Company plc (“Perrigo”) set forth below does not purport to be complete and is subject to and qualified by reference to the Irish Companies Act 2014 (the “Companies Act”) and Perrigo's memorandum and articles of association (as amended).

Perrigo Pharma International D.A.C

DocuSign Envelope ID: FAC9AAF4-6CC6-4A2D-A6CC-96680B333C45 Private & Confidential PERRIGO PHARMA INTERNATIONAL DAC The Sharp Building 10-12 Hogan Place Dublin 2 T (+353 1) 709 4000 F (+353 1) 709 4082 30 April 2024 Roberto Khoury Collado Dear Roberto, Perrigo Pharma International D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (Exact

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations Making Significant Progress on Stabilizing, Streamlining and Strengthening Organization to Build Long-Term Sustainable, Value Accretive Growth Delivered Fi

EXHIBIT 99.1 Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations Making Significant Progress on Stabilizing, Streamlining and Strengthening Organization to Build Long-Term Sustainable, Value Accretive Growth Delivered Fiscal Year 2024 Adjusted EPS of $2.57 the Mid-Point of the Company's Communicated Guidance Range, on Reported Loss of $(1.17) Per Share Fo

Amended and Restated Employment Agreement, effective as of February 26, 2025, by and between Perrigo Company and Patrick Lockwood-Taylor

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2025 Perrigo Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 +- Date of Report (Date of earliest event reported): January 15, 2025 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on December 27, 2024, pursuant to the provisions of Rule 12d2-2 (a).

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: September 28, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 28, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company

Reaffirmation Letter dated August 2, 2024, by and between Perrigo Corporation DAC and Grainne Quinn (

Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market

EXHIBIT 99.1 Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains1; Third Quarter 2024 Infant formula Net Sales

Employment Separation and Severance Letter Agreement fully executed on September 16, 2024 by and between the Company and Kyle L. Hanson (incorporated by reference from Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on November 6, 2024).

1 Initials June 11, 2024 PERSONAL AND CONFIDENTIAL Ms. Kyle L. Hanson RE: Employment Separation and Severance Perrigo Company Confidential Supplemental Wavier and Release Agreement 2 Dear Kyle: This Supplemental Waiver and Release Agreement 2 (“Agreement 2”) is entered into by and between Perrigo Company plc (“Perrigo” or “the Company”), and Kyle L. Hanson (“you” or “Employee” or “Executive”) on t

EX-10.1

List of Guarantor Subsidiaries

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of September 28, 2024, the obligors under (i) the 5.

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market

EXHIBIT 99.1 Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains1; Third Quarter 2024 Infant formula Net Sales

PRGO / Perrigo Company plc / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Perrigo Co PLC (Name of Issuer) Common Stock (Title of Class of Securities) G97822103 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Perrigo Company plc Perrigo Finance Unlimited C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Perrigo Company plc Perrigo Finance Unlimited Company (Exact name of registrant as specified in its charter) Ireland Not Applicable Ireland Not Applicable (State or other jurisdiction of incorporat

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on October 14, 2024, pursuant to the provisions of Rule 12d2-2 (a).

Consent of Warner Norcross + Judd LLP (included in Exhibit 5.5).

EX-5.5 Exhibit 5.5 Warner Norcross + Judd LLP Attorneys at Law 150 Ottawa Avenue N.W., Suite 1500 Grand Rapids, Michigan 49503 September 17, 2024 Perrigo Company plc The Sharp Building, Hogan Place Dublin 2, Ireland, D02 TY74 Ladies and Gentlemen: We are providing this opinion at the request of Perrigo Company, a Michigan corporation (the “Company”), in connection with the issuance and sale by Per

Underwriting Agreement, dated as of September 11, 2024, among the Issuer, the Company, the Subsidiary Guarantors, BofA Securities Inc. as representatives of the several underwriters for USD Notes named therein, BofA Securities Europe SA, HSBC Securities (USA) Inc., J.P. Morgan Securities plc, ING Financial Markets LLC, Morgan Stanley & Co. LLC, Wells Fargo Securities International Limited, BNP Paribas Securities Corp., Goldman Sachs & Co. LLC, Mizuho International plc, Capital One Securities, Inc., Goodbody Stockbrokers UC, Huntington Securities, Inc., MUFG Securities (Europe) N.V., PNC Capital Markets LLC and SG Americas Securities, LLC.

Exhibit 1.1 Perrigo Company plc Perrigo Finance Unlimited Company $715,000,000 6.125% Senior Notes due 2032 €350,000,000 5.375% Senior Notes due 2032 Underwriting Agreement September 11, 2024 BofA Securities, Inc. as Representative of the several Dollar Underwriters c/o BofA Securities, Inc. One Bryant Park New York, New York 10036 and BofA Securities Europe SA as Representative of the several Eur

PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY

EX-99.1 Exhibit 99.1 PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY Dublin, Ireland, September 17, 2024 — Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) today announced the closing of a registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the “Is

Consent of Warner Norcross + Judd LLP (included in Exhibit 5.4).

EX-5.4 Exhibit 5.4 Warner Norcross + Judd LLP Attorneys at Law 150 Ottawa Avenue N.W., Suite 1500 Grand Rapids, Michigan 49503 September 17, 2024 Perrigo Company plc The Sharp Building, Hogan Place Dublin 2, Ireland, D02 TY74 Ladies and Gentlemen: We are providing this opinion at the request of Perrigo Company, a Michigan corporation (the “Company”), in connection with the issuance and sale by Per

Consent of Fried, Frank, Harris, Shriver & Jacobson (London) LLP (included in Exhibit 5.3).

EX-5.3 Exhibit 5.3 FRIED, FRANK, HARRIS, SHRIVER & JACOBSON (LONDON) LLP 17 September 2024 Perrigo Company PLC Perrigo Finance Unlimited Company The Sharp Building, Hogan Place Dublin 2, Ireland, D02 TY74 Dear Sirs, Madams, 1. INTRODUCTION 1.1 We have acted as English law legal advisers to Perrigo Company plc, a public limited company incorporated under the laws of Ireland (the “Company”) and Perr

Sixth Supplemental Indenture dated as of September 17, 2024, among the Issuer, the Company, the Subsidiary Guarantors and Computershare Trust Company, N.A., as trustee.

EX-4.1 Exhibit 4.1 Execution Version PERRIGO FINANCE UNLIMITED COMPANY, as the Issuer, PERRIGO COMPANY PLC, as the Parent Guarantor, EACH OF THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO and COMPUTERSHARE TRUST COMPANY, N.A., as the Trustee SUPPLEMENTAL INDENTURE NO. 6 DATED AS OF SEPTEMBER 17, 2024 TO INDENTURE DATED AS OF DECEMBER 2, 2014 relating to $715,000,000 6.125% Senior Notes d

Seventh Supplemental Indenture dated as of September 17, 2024, among the Issuer, the Company, the Subsidiary Guarantors and Computershare Trust Company, N.A., as trustee.

Exhibit 4.3 Execution Version PERRIGO FINANCE UNLIMITED COMPANY, as the Issuer, PERRIGO COMPANY PLC, as the Parent Guarantor, EACH OF THE SUBSIDIARY GUARANTORS FROM TIME TO TIME PARTY HERETO, COMPUTERSHARE TRUST COMPANY, N.A., as the Trustee, ELAVON FINANCIAL SERVICES DAC as the Paying Agent, and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Registrar and Transfer Agent SUPPLEMENTAL INDENTURE N

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of i

Consent of Stibbe BV/SRL (included in Exhibit 5.6).

EX-5.6 Exhibit 5.6 By e-mail To: Perrigo Company plc Perrigo Finance Unlimited Company The Sharp Building, Hogan Place Dublin 2, Ireland, D02 TY74 (the Addressees) Wouter Ghijsels° T +32 2 533 54 73 F +32 2 533 52 91 [email protected] Stibbe Central Plaza Rue de Loxum 25 / Loksumstraat 25 1000 Brussels Belgium www.stibbe.com 17 September 2024 Perrigo – Belgian law capacity legal opinion i

Consent of Deputy General Counsel (included in Exhibit 5.7).

EX-5.7 Exhibit 5.7 September 17, 2024 Perrigo Company plc The Sharp Building Hogan Place Dublin 2, Ireland D02 TY74 Ladies and Gentlemen: In my capacity as Vice President and Deputy General Counsel of Perrigo Company plc, a public limited company incorporated under the laws of Ireland (the “Company”), I have acted as counsel for Perrigo Direct, Inc., a Georgia corporation (“Perrigo Direct”) and Pe

Calculation of Filing Fee Table (Form Type) Perrigo Company plc Perrigo Finance Unlimited Company Athena Neurosciences, LLC Chefaro Ireland Designated Activity Company Elan Pharmaceuticals, LLC Galpharm Healthcare Limited Galpharm International Limit

Exhibit 107.1 Calculation of Filing Fee Table 424(b)(5) (Form Type) Issuer: Perrigo Company plc Perrigo Finance Unlimited Company Guarantors: Athena Neurosciences, LLC Chefaro Ireland Designated Activity Company Elan Pharmaceuticals, LLC Galpharm Healthcare Limited Galpharm International Limited Gr8ness, LLC L. Perrigo Company Medgenix Benelux NV OCE-BIO BV Perrigo Belgium NV Perrigo Capital NV Om

Perrigo Finance Unlimited Company $715,000,000 6.125% Senior Notes due 2032 €350,000,000 5.375% Senior Notes due 2032

Filed Pursuant to Rule 424(b)(5) Registration No. 333-282001 PROSPECTUS SUPPLEMENT (To prospectus dated September 9, 2024) Perrigo Finance Unlimited Company $715,000,000 6.125% Senior Notes due 2032 €350,000,000 5.375% Senior Notes due 2032 Perrigo Finance Unlimited Company, a public unlimited company incorporated under the laws of Ireland (“Perrigo Finance” or the “Issuer”), and an indirect wholl

PERRIGO FINANCE UNLIMITED COMPANY $715,000,000 6.125% Senior Notes due 2032 (the “USD Notes”) €350,000,000 5.375% Senior Notes due 2032 (the “Euro Notes” and together with the USD Notes, the “Notes”) Pricing Term Sheet September 11, 2024

Issuer Free Writing Prospectus filed Pursuant to Rule 433 supplementing the Preliminary Prospectus Supplement Dated September 9, 2024 Registration Statement No.

Consent of Warner Norcross + Judd LLP (contained in Exhibit 5.4 to this registration statement).

EX-5.4 Exhibit 5.4 Warner Norcross + Judd LLP Attorneys at Law 150 Ottawa Avenue N.W., Suite 1500 Grand Rapids, Michigan 49503 September 9, 2024 Perrigo Company plc The Sharp Building, Hogan Place Dublin 2, Ireland, D02 TY74 Ladies and Gentlemen: Reference is made to the Registration Statement (the “Registration Statement”) on Form S-3 filed by Perrigo Company plc, a public limited company incorpo

Subject to Completion Preliminary Prospectus Supplement dated September 9, 2024

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-282001 The information in this prospectus supplement is not complete and may be changed. This prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. Subject to Completio

Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as Trustee with respect to the Base Indenture dated as of December 2, 2014.

Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) N

Consent of Stibbe BV/SRL (contained in Exhibit 5.5 to this registration statement).

EX-5.5 Exhibit 5.5 By e-mail To: Perrigo Company plc Perrigo Finance Unlimited Company The Sharp Building, Hogan Place Dublin 2, Ireland, D02 TY74 (the Addressees) Wouter Ghijsels° T +32 2 533 54 73 F +32 2 533 52 91 [email protected] Stibbe Central Plaza Rue de Loxum 25 / Loksumstraat 25 1000 Brussels Belgium www.stibbe.com 9 September 2024 Perrigo S-3 – Belgian law capacity Legal Opinio

Consent of Fried, Frank, Harris, Shriver & Jacobson (London) LLP (contained in Exhibit 5.3 to this registration statement).

EX-5.3 Exhibit 5.3 FRIED, FRANK, HARRIS, SHRIVER & JACOBSON (LONDON) LLP 9 September 2024 Perrigo Company PLC Perrigo Finance Unlimited Company The Sharp Building, Hogan Place Dublin 2, Ireland, D02 TY74 Dear Sirs, Madams, 1. INTRODUCTION 1.1 We have acted as English law legal advisers to Perrigo Company plc, a public limited company incorporated under the laws of Ireland (the “Company”) and Perri

As filed with the Securities and Exchange Commission on September 9, 2024

As filed with the Securities and Exchange Commission on September 9, 2024 Registration No.

Filing Fee Table.

Exhibit 107.1 Calculation of Filing Fee Table Form S-3 (Form Type) Issuer: Perrigo Company plc Perrigo Finance Unlimited Company Guarantors: Athena Neurosciences, LLC Chefaro Ireland Designated Activity Company Elan Pharmaceuticals, LLC Galpharm Healthcare Limited Galpharm International Limited Gr8ness, LLC L. Perrigo Company Medgenix Benelux NV OCE-BIO BV Perrigo Belgium NV Perrigo Capital NV Ome

Consent of Deputy General Counsel (contained in Exhibit 5.6 to this registration statement).

EX-5.6 Exhibit 5.6 September 9, 2024 Perrigo Company plc The Sharp Building Hogan Place Dublin 2, Ireland D02 TY74 Ladies and Gentlemen: In my capacity as Vice President and Deputy General Counsel of Perrigo Company plc, a public limited company incorporated under the laws of Ireland (the “Company”), I have acted as counsel for Perrigo Direct, Inc., a Georgia corporation (“Perrigo Direct”) and Per

1 Perrigo Issues Voluntary Recall of One Batch of Premium Infant Formula with Iron Milk- Based Powder Due to Elevated Levels of Vitamin D Perrigo Consumer Affairs Contact Information: 1-800-538-9543 Dublin, Ireland and Allegan, MI – August 8, 2024 –

1 Perrigo Issues Voluntary Recall of One Batch of Premium Infant Formula with Iron Milk- Based Powder Due to Elevated Levels of Vitamin D Perrigo Consumer Affairs Contact Information: 1-800-538-9543 Dublin, Ireland and Allegan, MI – August 8, 2024 – Perrigo Company plc is issuing a voluntary recall at the retailer and warehouse level of three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder due to levels of Vitamin D above the maximum level permitted.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 Perrigo Company pl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

Exhibit 22

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of June 29, 2024, the obligors under (i) the 5.

Compromise Waiver Agreement dated April 5, 2024, by and between Perrigo Corporation DAC and Grainne Quinn (incorporated by reference from Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on August 2, 2024).

Delivered Adjusted Diluted Earnings Per Share Results as Expected; Reaffirm Fiscal 2024 Adjusted Diluted EPS Outlook Progressing One Perrigo Blueprint: On Target to Deliver Project Energize Goals; Enhancing Capabilities; Completed Divestment of HRA P

EXHIBIT 99.1 Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations Delivered Adjusted Diluted Earnings Per Share Results as Expected; Reaffirm Fiscal 2024 Adjusted Diluted EPS Outlook Progressing One Perrigo Blueprint: On Target to Deliver Project Energize Goals; Enhancing Capabilities; Completed Divestment of HRA Pharma Rare Diseases Business on July 10, 2024 Second Qua

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: June 29, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 29, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2024 Perrigo Company pl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

greement dated June 11, 2024, by and between the Company and Kyle L. Hanso

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission File Number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2024 Perrigo Company plc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission File Number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpo

Perrigo Completes Divestment of HRA Pharma Rare Diseases Business

EX-99.1 Exhibit 99.1 Perrigo Completes Divestment of HRA Pharma Rare Diseases Business Dublin, Ireland – July 10, 2024 – Perrigo Company plc (NYSE PRGO) (“Perrigo” or the “Company”), a leading provider of Consumer Self-Care Products, today announced that it has completed the previously announced divestment of the HRA Pharma Rare Diseases business to Esteve Healthcare, S.L. (“ESTEVE”) for a total c

Purchase and Sale Agreement, dated as of July 3, 2024, by and among Perrigo Company plc and Esteve Healthcare S.L.

EX-2.1 Exhibit 2.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL PURCHASE AND SALE AGREEMENT BY AND BETWEEN PERRIGO COMPANY PLC AND ESTEVE HEALTHCARE, S.L. Dated as of July 3, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1.1 Definitions

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 OR [ ] TRANSITION REPORT PURSUANT TO SECT

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission File Number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpo

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission File Number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PERRIGO COMPANY PLC (Exact name of registrant as specified in its charter) Ireland 001-36353 Not Applicable (State or other jurisdiction of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PERRIGO COMPANY PLC (Exact name of registrant as specified in its charter) Ireland 001-36353 Not Applicable (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74

Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations Delivered Adjusted Diluted Earnings Per Share Results Above Projection, Due Primarily to Timing of Infant Formula Shipments; Reaffirm 2024 Financial Outlook Advanced Augm

EXHIBIT 99.1 Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations Delivered Adjusted Diluted Earnings Per Share Results Above Projection, Due Primarily to Timing of Infant Formula Shipments; Reaffirm 2024 Financial Outlook Advanced Augmenting and Strengthening of Infant Formula Facilities, Recovery of Manufacturing Volumes Underway Progressed Blueprint to Build One Perri

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

List of Guarantor Subsidiaries

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of March 30, 2024, the obligors under (i) the 5.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: March 30, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission File Number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission File Number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission File Number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 Perrigo Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program Net Sales from Continuing Operations Were a Fourth Quarter and Fiscal Year Record Delivered Fiscal Year 2023 Doub

EXHIBIT 99.1 Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program Net Sales from Continuing Operations Were a Fourth Quarter and Fiscal Year Record Delivered Fiscal Year 2023 Double-Digit Improvement in Gross Profit, Operating Income and EPS, Year-Over-Year Achieved Sixth Consecutive Quarter of Year-Over-Year Gross

Amendment No. 2 to Employment Agreement by and between the Company and Patrick Lockwood-Taylor, effective as of February 21, 2024 (

US.362378911.01 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT The Employment Agreement made and entered into effective June 5, 2023 (the “Agreement”) by and between Perrigo Company, a Michigan corporation (the “Company”), and Patrick Lockwood-Taylor (“Executive”), as amended, is hereby amended by this Amendment No. 2, effective as of February 21, 2024 (this “Amendment”). WHEREAS, the Company and Executi

As Filed with the Securities and Exchange Commission on February 27, 2024

As Filed with the Securities and Exchange Commission on February 27, 2024 Registration Statement No.

List of Guarantor Subsidiaries (filed herewith)

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of December 31, 2023, the obligors under (i) the 5.

Separation Agreement between the Company and James Dillard III, executed November 14, 2023 (filed herewith).

US.359387005.04 Initials September 29, 2023 PERSONAL AND CONFIDENTIAL Mr. James Dillard III RE: Employment Separation and Severance Perrigo Company Confidential Wavier and Release Agreement Dear Jim: Your employment with Perrigo Company will end October 31, 2023 (“Executive’s Severance Date”); you will have no continued employment opportunity with Perrigo. This Waiver and Release Agreement (“the A

errigo's Clawback Policy (

PERRIGO COMPANY PLC COMPENSATION RECOVERY POLICY SECTION 1. POLICY The Board of Directors (the “Board”) of Perrigo Company plc (the “Company”) has adopted this Compensation Recovery Policy (this “Policy”) pursuant to Rule 10D-1 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), the Securities and Exchange Commission regulations promulgated thereunder, and applicable New Y

Subsidiaries of the Registrant

Exhibit 21 PERRIGO SUBSIDIARIES Name of Subsidiary State/Country of Incorporation Chefaro Ireland Designated Activity Company Ireland Habsont Unlimited Company Ireland Omega Teknika Designated Activity Company Ireland Perrigo Company plc Ireland Perrigo Corporation Designated Activity Company Ireland Perrigo Finance Unlimited Company Ireland Perrigo Holdings Unlimited Company Ireland Perrigo Inter

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Perrigo Company plc (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value €0.

PRGO / Perrigo Company plc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01689-perrigocoplc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Perrigo Co PLC Title of Class of Securities: Common Stock CUSIP Number: G97822103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the r

PRGO / Perrigo Company plc / BARROW HANLEY MEWHINNEY & STRAUSS LLC - SCHEDULE 13G Passive Investment

SC 13G 1 prgo13g02132024.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Perrigo Co PLC (Name of Issuer) Common Stock (Title of Class of Securities) G97822103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check appropriate box to designate the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2023 Perrigo Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

Amendment No. 1 and Incremental Assumption Agreement to Credit Agreement, dated December 15, 2023, among Perrigo Investments, LLC, as borrower, Perrigo Company plc, as parent, the Guarantors, the Incremental Term B Lenders, and JPMorgan Chase Bank, N.A., as administrative agent (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 15, 2023) (File No. 001-36353).

EX-10.1 Exhibit 10.1 Execution Version This AMENDMENT NO. 1 AND INCREMENTAL ASSUMPTION AGREEMENT (this “Amendment No. 1”), dated as of December 15, 2023 and entered into by and among Perrigo Investments, LLC, a Delaware limited liability company (the “Borrower”), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the “Parent”), the other Guarantors party hereto, the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2023 Perrigo Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

Perrigo Announces Early Results of Cash Tender Offer for Notes

Exhibit 99.1 Perrigo Announces Early Results of Cash Tender Offer for Notes DUBLIN, November 29, 2023 — Perrigo Company plc (NYSE: PRGO) (the “Company”), a leading provider of Consumer Self-Care Products, today announced the early tender results of the previously announced cash tender offer (the “Tender Offer”) by Perrigo Finance Unlimited Company, its wholly-owned finance subsidiary (the “Issuer”

Perrigo Announces Cash Tender Offer for Notes

EX-99.1 Exhibit 99.1 Perrigo Announces Cash Tender Offer for Notes DUBLIN, November 10, 2023 — Perrigo Company plc (NYSE: PRGO) (the “Company”), a leading provider of Consumer Self-Care Products, today announced that Perrigo Finance Unlimited Company, its wholly-owned finance subsidiary (the “Issuer”), commenced a cash tender offer (the “Tender Offer”) to purchase its 3.900% Senior Notes due 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 Perrigo Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations Realized Third Quarter Double-Digit Gross Profit, Operating Income and EPS Growth Delivered Third Quarter Gross Margin and Operating Margin Expansion Year-Ove

EXHIBIT 99.1 Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations Realized Third Quarter Double-Digit Gross Profit, Operating Income and EPS Growth Year-Over-Year Delivered Third Quarter Gross Margin and Operating Margin Expansion Year-Over-Year and Sequentially Achieved Fifth Consecutive Quarter of Double-Digit Adjusted Gross Profit, Adjusted Operating Incom

Amendment No. 3 to the Perrigo Company plc 2019 Long-Term Incentive Plan, dated November 1, 2023 (incorporated by Reference from Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on November 7, 2023) (File No. 001-36353).

AMENDMENT NO. 3 TO THE PERRIGO COMPANY PLC 2019 LONG-TERM INCENTIVE PLAN WHEREAS, Perrigo Company plc (the “Company”) sponsors the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”); and WHEREAS, the Company desires to amend the Plan to modify the definition of “Retirement” in certain respects. NOW, THEREFORE, by virtue and in exercise of the amending authority reserved by the Plan spo

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

Amended and Restated Perrigo Company plc Annual Incentive Plan, dated August 2, 2023 (incorporated by reference from Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 7, 2023) (File No. 001-36353).

PERRIGO COMPANY PLC ANNUAL INCENTIVE PLAN Perrigo Company, a Michigan corporation, adopted the Perrigo Company Annual Incentive Plan (“AIP,” previously referred to as the “MIB”) for the purpose of enhancing its ability to attract and retain highly qualified employees and to provide additional financial incentives to such employees to promote the success of Perrigo Company and its subsidiaries.

Amendment No. 1 to Employment Agreement by and between the Company and Patrick Lockwood-Taylor, effective as of September 28, 2023 (incorporated by Reference from Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q filed on November 7, 2023) (File No. 001-36353).

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT The Employment Agreement made and entered into effective June 5, 2023 (the “Agreement”) by and between Perrigo Company, a Michigan corporation (the “Company”), and Patrick Lockwood-Taylor (“Executive”), is hereby amended by this Amendment No. 1, effective as of September 28, 2023 (this “Amendment”). WHEREAS the Company and Executive previously intended for E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company

Amendment No. 2 to the Perrigo Company plc 2019 Long-Term Incentive Plan, dated August 2, 2023 (incorporated by Reference from Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on November 7, 2023) (File No. 001-36353).

AMENDMENT NO. 2 TO THE PERRIGO COMPANY PLC 2019 LONG-TERM INCENTIVE PLAN WHEREAS, Perrigo Company plc (the “Company”) sponsors the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”); and WHEREAS, the Company desires to amend the Plan to reflect the adoption of a separate Compensation Recovery Policy. NOW, THEREFORE, by virtue and in exercise of the amending authority reserved by the Pl

List of Guarantor Subsidiaries

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of September 30, 2023, the obligors under (i) the 5.

* * *

United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2023 Perrigo Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of i

1

United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: July 1, 2023 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: July 1, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (E

Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing Operations Achieved Year-Over-Year and Sequential Gross and Operating Margin Expansion Delivered Strong Operating Income and EPS Growth Reaffirming 2023 Outlook

EXHIBIT 99.1 Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing Operations Achieved Year-Over-Year and Sequential Gross and Operating Margin Expansion Delivered Strong Operating Income and EPS Growth Reaffirming 2023 Outlook Second Quarter 2023 Highlights: •Second quarter net sales of $1.2 billion grew 6.4%, or 6.6% on a constant currency1 basis, versus the prior yea

List of Guarantor Subsid

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of July 1, 2023, the obligors under (i) the 5.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2022 OR [ ] TRANSITION REPORT PURSUANT TO SECT

Form of Restricted Stock Unit Award Agreement (Performance Based) under the Perrigo Company plc 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.2 on Form 8-K filed on June 8, 2023) (File No. 001-36353).

EX-10.2 Exhibit 10.2 PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Performance-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Pl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2023 Perrigo Company plc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpo

Form of Restricted Stock Unit Award Agreement (Service Based) under the Perrigo Company plc 2019 Long-Term Incentive Plan (incorporated by reference from Exhibit 10.3 on Form 8-K filed on June 8, 2023) (File No. 001-36353).

EX-10.3 Exhibit 10.3 PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (SERVICE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Service-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), ef

Employment Agreement, effective as of June 30, 2023, by and between Perrigo Company and Patrick Lockwood-Taylor

EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into, as of June 5, 2023 with employment commencing on June 30, 2023 (the “Effective Date”) by and between Perrigo Company, a Michigan corporation (the “Company”), and Patrick Lockwood-Taylor (“Executive”). WHEREAS, the Company desires to employ Executive as its Chief Executive Officer and Pr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PERRIGO COMPANY PLC (Exact name of registrant as specified in its charter) Ireland 001-36353 Not Applicable (State or other jurisdiction (Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PERRIGO COMPANY PLC (Exact name of registrant as specified in its charter) Ireland 001-36353 Not Applicable (State or other jurisdiction (Commission (IRS Employer of incorporation or organization) File Number) Identification No.) The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Perrigo Company plc (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

Forms of rTSR Performance-Based Restricted Stock Unit Award Agreement (incorporated by reference from Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on May 9, 2023) (File No. 001-36353).

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Performance-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

Forms of OI Performance-Based Restricted Stock Unit Award Agreement (incorporated by reference from Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on May 9, 2023) (File No. 001-36353).

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Performance-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

Forms of Performance-Based and Service-Based Restricted Stock Unit Award Agreements for Murray Kessler (filed herewith).

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (PERFORMANCE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Performance-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

List of Guarantor Subsidiaries

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of April 1, 2023, the obligors under (i) the 5.

Forms of Service-based Restricted Stock Unit Award Agreement (incorporated by reference from Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q filed on May 9, 2023) (File No. 001-36353).

PERRIGO COMPANY PLC RESTRICTED STOCK UNIT AWARD AGREEMENT (SERVICE-BASED) (Under the Perrigo Company plc 2019 Long-Term Incentive Plan) TO: Participant Name RE: Notice of Restricted Stock Unit Award (Service-Based) This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”).

Perrigo Announces Chief Executive Officer Retirement and Succession Plan

EX-99.1 Exhibit 99.1 Perrigo Announces Chief Executive Officer Retirement and Succession Plan Dublin, Ireland – May 9, 2023 – Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that Murray S. Kessler has notified the Company of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023. Mr. Kessler

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: April 1, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: April 1, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to Commission file number 001-36353 Perrigo Company plc (Ex

Amendment No. 1 to Annual Incentive Plan (filed herewith).

AMENDMENT NO. 1 TO THE PERRIGO COMPANY PLC ANNUAL INCENTIVE PLAN WHEREAS, Perrigo Company plc (the “Company”) sponsors the Perrigo Company PLC Annual Incentive Plan, As Amended and Restated February 13, 2019 (the "Plan"); WHEREAS, the Company desires to amend the Plan to change the eligibility requirement for payment of an Incentive Bonus. NOW, THEREFORE, by virtue and in exercise of the amending

Perrigo Reports First Quarter Fiscal Year 2023 Financial Results From Continuing Operations

EXHIBIT 99.1 Perrigo Reports First Quarter Fiscal Year 2023 Financial Results From Continuing Operations First Quarter 2023 Highlights: •First quarter net sales grew 10.0% versus the prior year quarter to $1.2 billion. Constant currency net sales(1) increased 13.0% and organic(2) net sales grew 6.4% compared to the prior year quarter. •Consumer Self-Care Americas ("CSCA") and Consumer Self-Care In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2023 Perrigo Company pl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box : ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box : ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

Filing Fee Table

EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Perrigo Company plc (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value €0.

Subsidiaries of the Registrant

Exhibit 21 PERRIGO SUBSIDIARIES Name of Subsidiary State/Country of Incorporation Chefaro Ireland Designated Activity Company Ireland Habsont Unlimited Company Ireland Omega Teknika Designated Activity Company Ireland Perrigo Company plc Ireland Perrigo Corporation Designated Activity Company Ireland Perrigo Finance Unlimited Company Ireland Perrigo Holdings Unlimited Company Ireland Perrigo Inter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (Exact

incorporated by reference from Exhibit 10.16 to the Company’s Annual Report on Form 10-K filed on February 28, 2023 ) (File No. 001-36353).

irishseveranceprogrammea THE PERRIGO EMPLOYEE SEVERANCE PROGRAMME IRELAND SECTION 1 INTRODUCTION SECTION 2 TERMS OF SEVERANCE PROGRAMME SECTION 3 WHAT HAPPENS TO ALL BENEFITS SECTION 4 REDUNDANCY TAXATION SECTION 5 SOCIAL WELFARE ENTITLEMENTS SECTION 6 OTHER INFORMATION/ADVICE SECTION 7 PRACTICAL “TO DO” LIST UPON LEAVING PERRIGO SECTION 8 USEFUL FUTURE CONTACT DETAILS IMPORTANT NOTICES 1.

incorporated by reference from Exhibit 10.13 to the Company’s Annual Report on Form 10-K filed on February 28, 2023) (File No. 001-36353).

Perrigo Company Nonqualified Deferred Compensation Plan As Amended and Restated Effective January 1, 2021 ACTIVE.

Powers of Attorney (included as part of the signature page hereto)

S-8 As Filed with the Securities and Exchange Commission on February 28, 2023 Registration Statement No.

List of Guarantor Subsidiaries (filed herewith)

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of December 31, 2022, the obligors under (i) the 5.

Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations

EXHIBIT 99.1 Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations Highlights: •Perrigo fiscal year net sales grew 7.6% versus the prior year to $4.5 billion. Constant currency net sales(1) increased 12.8% and organic(2) net sales grew a robust 8.8% compared to the prior year. •Fourth quarter net sales grew 4.6% to $1.2 billion versus the prior year quarter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 Perrigo Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

PRGO / Perrigo Company PLC / BARROW HANLEY MEWHINNEY & STRAUSS LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Perrigo Co PLC (Name of Issuer) Common Stock (Title of Class of Securities) G97822103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check appropriate box to designate the rule pursuant to which this Schedule is f

PRGO / Perrigo Company PLC / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Perrigo Co. plc Title of Class of Securities: Common Stock CUSIP Number: G97822103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2023 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

Fifth Supplemental Indenture by and among Perrigo Company plc, Perrigo Finance Unlimited Company, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National Association, as Trustee, dated as of September 8, 2022 (incorporated by reference from Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q filed on November 8, 2022) (File No. 001-36353).

SUPPLEMENTAL INDENTURE NO. 5 Supplemental Indenture No. 5, dated as of September 8, 2022, (this ?Fifth Supplemental Indenture?) among Perrigo Finance Unlimited Company, an Irish public unlimited company (formerly, Perrigo Finance plc) (the ?Company?), Perrigo Company plc, an Irish public limited company (the ?Parent Guarantor?), Perrigo Investments, LLC, Athena Neurosciences, LLC, Elan Pharmaceuti

Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing Operations

EXHIBIT 99.1 Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing Operations Highlights: •Perrigo achieved third quarter net sales of $1.1 billion, an increase of 5.5%, or 12.3% excluding the impact of currency translation, versus the prior year quarter. Year-to-date net sales increased 8.7%, or 14.0% excluding the impact of currency translation, versus the prior year p

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: October 1, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: October 1, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 Perrigo Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

List of Guarantor Subsidiaries

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of October 1, 2022, the obligors under (i) the 5.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: July 2, 2022 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: July 2, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (E

PERRIGO REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS

EXHIBIT 99.1 PERRIGO REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS Second Quarter 2022 Highlights: ?Perrigo achieved second quarter net sales of $1.1 billion, an increase of 14.3%, or 20.2% excluding the impact of currency translation, versus the prior year quarter. Organic(1) net sales increased 17.2%, driven by continued strong global demand for the Company

List of Guarantor

Exhibit 22 Subsidiary Guarantors and Issuers of Guaranteed Securities and Affiliates Whose Securities Collateralize Securities of the Registrant As of July 2, 2022, the obligors under (i) the 5.

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

Third Supplemental Indenture by and among Perrigo Company plc, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National Association, as Trustee, dated as of May 25, 2022 (incorporated by reference from Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q filed on August 9, 2022) (File No. 001-36353).

THIRD SUPPLEMENTAL INDENTURE Third Supplemental Indenture, dated as of May 25, 2022, (this ?Third Supplemental Indenture?) among Perrigo Company plc, an Irish public limited company (the ?Company?), Perrigo Investments, LLC, Perrigo Investments Capital, Inc.

Fourth Supplemental Indenture by and among Perrigo Company plc, Perrigo Finance Unlimited Company, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National Association, as Trustee, dated as of May 25, 2022 (incorporated by reference from Exhibit 4.2 to the Company’s Quarterly Report on Form 10-Q filed on August 9, 2022) (File No. 001-36353).

SUPPLEMENTAL INDENTURE NO. 4 Supplemental Indenture No. 4, dated as of May 25, 2022, (this ?Fourth Supplemental Indenture?) among Perrigo Finance Unlimited Company, an Irish public unlimited company (formerly, Perrigo Finance plc) (the ?Company?), Perrigo Company plc, an Irish public limited company (the ?Parent Guarantor?), Perrigo Investments, LLC, Perrigo Investments Capital, Inc., Athena Neuro

Independent Auditors’ Report

Exhibit 99.1 KPMG Audit T?l?phone : +33 (0)1 55 68 68 68 Tour EQHO T?l?copie : +33 (0)1 55 68 73 00 2 Avenue Gambetta Site internet : www.kpmg.fr CS 60055 92066 Paris la D?fense Cedex France Independent Auditors? Report To the Chairman of HERA S.A.S.; Qualified Opinion We have audited the consolidated financial statements of HERA S.A.S. and its subsidiaries (the Company), which comprise the consol

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF PERRIGO COMPANY PLC

Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF PERRIGO COMPANY PLC On April 29, 2022, Perrigo Company PLC (?Perrigo? or the ?Company?) consummated the acquisition of H?ra SAS (?H?ra?), a leading global consumer self-care company, from funds affiliated with private equity firm Astorg and Goldman Sachs Asset Management (the ?Acquisition?) in an all-cash transaction. Per

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other j

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECT

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on May 31, 2022, pursuant to the provisions of Rule 12d2-2 (a).

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: April 2, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: April 2, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (

, 2022 (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 11, 2022) (File No. 001-36353).

Exhibit 10.1 May 2 2022 Eduardo Bezerra Dear Eduardo, On behalf of the Perrigo Board of Directors, I would like to formally congratulate you on becoming part of the Perrigo family and an integral part of my leadership team. For more than 130 years, Perrigo has provided high quality, affordable self-care products to families around the world and there is no greater reward than helping make lives be

PERRIGO ANNOUNCES PLANNED LEADERSHIP SUCCESSION Mr. Eduardo G. Bezerra named EVP, Chief Financial Officer Mr. Todd Kingma to retire after 19 years of service; Ms. Kyle L. Hanson to be named EVP, General Counsel and Corporate Secretary

Exhibit 99.1 PERRIGO ANNOUNCES PLANNED LEADERSHIP SUCCESSION Mr. Eduardo G. Bezerra named EVP, Chief Financial Officer Mr. Todd Kingma to retire after 19 years of service; Ms. Kyle L. Hanson to be named EVP, General Counsel and Corporate Secretary Dublin, Ireland ? May 11, 2022 ? Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care products, today made two announcements regar

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpo

PERRIGO REPORTS FIRST QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS, RAISES GUIDANCE

EXHIBIT 99.1 PERRIGO REPORTS FIRST QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS, RAISES GUIDANCE Highlights: ?Perrigo achieved first quarter net sales of $1.1 billion, an increase of 6.4% versus the prior year quarter. Organic(1) net sales increased 9.7%, led by continued strong consumer demand, particularly for cough/cold products globally and infant formula in the U.S. ?

PERRIGO COMPLETES THE ACQUISITION OF HRA PHARMA

Exhibit 99.1 FOR IMMEDIATE RELEASE PERRIGO COMPLETES THE ACQUISITION OF HRA PHARMA Dublin, Ireland ? May 2, 2022 ? Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that on April 29, 2022 it completed the previously announced acquisition of H?ra SAS (?HRA?) for ?1.8 billion, or approximately $1.9 billion based on current exchange rates, in cash, a

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

PERRIGO ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA

EX-99.1 2 d292050dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE PERRIGO ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA Dublin, Ireland – April 28, 2022 – Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that the closing date of the previously announced acquisition of Héra SAS (“HRA” or “HRA Pharma”) is expected to occur on April 2

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

Term Loan and Revolving Credit Agreement by and among Perrigo Company plc, as parent, Perrigo Investments, LLC, as a borrower, the Designated Borrowers, the Lenders, the Issuing Banks, and the Swing Line Lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent, and as Collateral Agent, dated as of April 20, 2022 (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 20, 2022).

Exhibit 10.1 EXECUTION VERSION Deal CUSIP Number: 71429TAA8 Revolving Facility CUSIP Number: 71429TAE0 Initial Term B Facility CUSIP Number: 71429TAC4 Term A Facility CUSIP Number: 71429TAB6 CREDIT AGREEMENT dated as of April 20, 2022 among PERRIGO COMPANY PLC, as Parent PERRIGO INVESTMENTS, LLC, as the Initial Borrower THE OTHER SUBSIDIARIES OF PARENT NAMED HEREIN, as Designated Borrowers, THE LE

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

PERRIGO ANNOUNCES CLOSING OF $2.6 BILLION SENIOR SECURED CREDIT FACILITIES

Exhibit 99.1 PERRIGO ANNOUNCES CLOSING OF $2.6 BILLION SENIOR SECURED CREDIT FACILITIES Dublin, Ireland?April 20, 2022 ? Perrigo Company plc (NYSE: PRGO) (?Perrigo? or the ?Company?), a leading provider of Consumer Self-Care Products, today announced that it closed its previously announced senior secured credit facilities. The new facilities consist of (i) a $1.0 billion five-year revolving credit

PERRIGO ANNOUNCES LAUNCH OF PRIVATE NOTES OFFERING

Exhibit 99.1 PERRIGO ANNOUNCES LAUNCH OF PRIVATE NOTES OFFERING Dublin, Ireland - April 4, 2022 ? Perrigo Company plc (NYSE: PRGO) (?Perrigo? or the ?Company?), a leading provider of Quality, Affordable Self-Care Products, today announced that it has launched a private offering (the ?Offering?) of $500 million aggregate principal amount of senior notes due 2030 (the ?Notes?), subject to market and

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

Non GAAP Disclosure

Exhibit 99.1 Non GAAP Disclosure The following provides a reconciliation of pro forma EBITDA and pro forma Adjusted EBITDA to pro forma net income (loss), which is the most directly comparable financial measure prepared in accordance with GAAP: Pro Forma Twelve months ended December 31, 2021 in millions (unaudited) Perrigo H?ra (?) Conversion and Adjustments (a) Pro Forma Condensed Combined Pro fo

HERA S.A.S. Statutory auditor’s report on the consolidated financial statements as of and for the years ended December 31, 2020 and 2021 Years ended December 31, 2020 and 2021 HERA S.A.S. 200, avenue de Paris – 92320 Chtillon KPMG S.A a French limite

Exhibit 99.2 KPMG Audit Telephone: +33 (0)1 55 68 68 68 Tour EQHO Telefax: +33 (0)1 55 68 73 00 2 Avenue Gambetta Internet: www.kpmg.fr CS 60055 92066 Paris la D?fense Cedex France HERA S.A.S. Statutory auditor?s report on the consolidated financial statements as of and for the years ended December 31, 2020 and 2021 Years ended December 31, 2020 and 2021 HERA S.A.S. 200, avenue de Paris ? 92320 Ch

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

PERRIGO ANNOUNCES LAUNCH OF SYNDICATION OF NEW SENIOR SECURED CREDIT FACILITIES

Exhibit 99.4 PERRIGO ANNOUNCES LAUNCH OF SYNDICATION OF NEW SENIOR SECURED CREDIT FACILITIES Dublin, Ireland?March 28, 2022 ? Perrigo Company plc (NYSE: PRGO) (?Perrigo? or the ?Company?), a leading provider of Quality, Affordable Self-Care Products, today announced that it has launched the syndication of new senior secured credit facilities expected to consist of (i) a $1,000 million five-year re

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF PERRIGO COMPANY PLC

Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF PERRIGO COMPANY PLC On September 8, 2021, Perrigo Company PLC (?Perrigo? or the ?Company?) announced its intention to acquire H?ra SAS (?H?ra?), a leading global consumer self-care company, from funds affiliated with private equity firm Astorg and Goldman Sachs Asset Management (the ?Proposed Acquisition?) in an all-cash

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defini

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (Exact

PERRIGO REPORTS FOURTH QUARTER & FISCAL YEAR 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS

EXHIBIT 99.1 PERRIGO REPORTS FOURTH QUARTER & FISCAL YEAR 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS Highlights: ?Fourth quarter net sales grew 4.9%, or 5.7% excluding the impact of currency, compared to the prior year to $1.1 billion led by a strong rebound in the demand for cough/cold products. ?Fiscal year 2021 net sales increased 1.2%, or down 0.3% excluding the impact of currency, to $

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2022 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

Subsidiaries of the Registrant.

Exhibit 21 PERRIGO SUBSIDIARIES Name of Subsidiary State/Country of Incorporation Chefaro Ireland Designated Activity Company Ireland Habsont Unlimited Company Ireland Irish Biosciences Venture Capital Fund Ireland Omega Teknika Designated Activity Company Ireland Perrigo Company plc Ireland Perrigo Corporation Designated Activity Company Ireland Perrigo Finance Unlimited Company Ireland Perrigo H

PRGO / Perrigo Company PLC / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Perrigo Co. plc Title of Class of Securities: Common Stock CUSIP Number: G97822103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rul

PRGO / Perrigo Company PLC / BARROW HANLEY MEWHINNEY & STRAUSS LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Perrigo Co PLC (Name of Issuer) Common Stock (Title of Class of Securities) G97822103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check appropriate box to designate the rule pursuant to which this Schedule is f

Amendment No. 3 to that certain Revolving Credit Agreement, dated as of December 3, 2021 and entered into by and among Perrigo Finance, the Company, each lender party thereto and JPMorgan Chase Bank, N.A., as administrative agent.

Exhibit 10.2 Execution Version This AMENDMENT NO. 3 (this ?Amendment No. 3?), dated as of December 3, 2021 and entered into by and among Perrigo Finance Unlimited Company, a public unlimited company organized under the laws of Ireland (the ?Revolving Borrower?), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the ?Company?), each lender party hereto (each a ?Cons

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

Amendment No. 2 to that certain Term Loan Credit Agreement, dated as of December 3, 2021 and entered into by and among Perrigo Finance, the Company, each lender party thereto and JPMorgan Chase Bank, N.A., as administrative agent.

Exhibit 10.1 Execution Version This AMENDMENT NO. 2 (this ?Amendment No. 2?), dated as of December 3, 2021 and entered into by and among Perrigo Finance Unlimited Company, a public unlimited company organized under the laws of Ireland (the ?Term Facility Borrower?), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the ?Company?), each lender party hereto (each a ?

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

As Filed with the Securities and Exchange Commission on November 15, 2021

As Filed with the Securities and Exchange Commission on November 15, 2021 Registration Statement No.

Supplement to Letter Agreement, dated as of August 11, 2021, by and between the Company and Raymond Silcock (filed herewith)

August 11, 2021 Exhibit 10.4 Raymond Silcock Dear Ray, I would like to update your March 17, 2019 Offer Letter to reflect that your primary work location and residency have changed. The last two bullet points in your offer letter are replaced in their entirety as follows: ?Your primary work location will be West Palm Beach, Florida. You will be eligible for payment of, or reimbursement for, all bu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: October 2, 2021 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: October 2, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

PERRIGO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS Major Strategic Initiatives Completed During Q3: - Closed sale of Rx business for $1.6B - Announced Acquisition of HRA Pharma for €1.8B - Settled €1.6B Irish Tax Assessme

EXHIBIT 99.1 PERRIGO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS Major Strategic Initiatives Completed During Q3: - Closed sale of Rx business for $1.6B - Announced Acquisition of HRA Pharma for ?1.8B - Settled ?1.6B Irish Tax Assessment for Net Cash Outlay of ?266M - Awarded ?355M From Belgium Arbitration Decision Supply Chain Disruption and Higher Input Costs Negative

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inc

Securities Sale Agreement, dated as of October 20, 2021, by and among Perrigo Company plc, Habsont Unlimited Company and certain other parties set forth therein

Exhibit 2.1 EXECUTION VERSION SECURITIES SALE AGREEMENT relating to the sale of H?ra SAS HRA Lux S.? r.l. Cemag SAS Vaneau SAS Fonds Commun de Placement d?Entreprise H?ra The persons listed in Schedule 1 (as Vendors) and Habsont Unlimited Company (as Purchaser) Perrigo Company plc, executing this Agreement for the purpose of Clause 21 (as Purchaser Guarantor) October 20, 2021 CONTENTS Page 1. DEFI

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inco

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of i

Put Option Agreement, dated as of September 8, 2021, by and among Perrigo Company plc, Habsont Unlimited Company and certain other parties set forth therein (incorporated by reference from Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on September 9, 2021) (File No. 001-36353).

EX-2.1 2 d229600dex21.htm EX-2.1 Exhibit 2.1 EXECUTION VERSION HABSONT UNLIMITED COMPANY To: HRA Lux 2, rue Albert Borschette L-1246 Luxembourg David Wright [**] Geoff Allan [**] Erin Gainer [**] Cemag SAS 55, rue de Turbigo 75003 Paris Vaneau SAS 21, rue Monsieur 75007 Paris On September 8, 2021 STRICTLY CONFIDENTIAL Dear Sirs, We refer to our recent discussions relating to the contemplated direc

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

1

Exhibit 99.1 FOR RELEASE Perrigo to Acquire Leading Consumer Self-Care Company, HRA Pharma ? Transaction would complete Perrigo?s three-year transformation plan to become a global leader in consumer self-care; positions Perrigo to deliver top-tier net sales growth and double-digit EPS growth, with significant margin expansion. ? Would add HRA?s focused portfolio of market leading, high growth OTC

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of in

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: July 3, 2021 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: July 3, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36353 Perrigo Company plc (E

PERRIGO REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS Fiscal 2021 Net Sales Guidance Reaffirmed Adjusted EPS Now Expected Towards the Lower End of the Guidance Range due to Lower Sales Volumes and Higher Input Costs U.S. an

EXHIBIT 99.1 PERRIGO REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS Fiscal 2021 Net Sales Guidance Reaffirmed Adjusted EPS Now Expected Towards the Lower End of the Guidance Range due to Lower Sales Volumes and Higher Input Costs U.S. and E.U. Consumer Self-Care Take Away Rebounded Sharply in the Quarter Divestiture of RX Business for $1.55 Billion Completed on July 6, 20

Amendment No. 1 and Waiver to 2019 Term Loan, dated as of August 10, 2021, by and among Perrigo Finance Unlimited Company, Perrigo Company plc, JPMorgan Chase Bank, N.A., and the other lenders party thereto, dated as of August 15, 2019 (

Exhibit 10.2 This AMENDMENT NO. 1 AND WAIVER (this ?Amendment No. 1?), dated as of August 10, 2021 and entered into by and among Perrigo Finance Unlimited Company, a public unlimited company organized under the laws of Ireland (the ?Term Facility Borrower?), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the ?Company?), each lender party hereto (each a ?Consenti

Amendment No. 2 and Waiver to 2018 Revolver, dated as of August 10, 2021, by and among Perrigo Finance Unlimited Company, Perrigo Company plc, JPMorgan Chase Bank, N.A., and the other lenders party thereto, dated as of August 15, 2019 (

Exhibit 10.3 This AMENDMENT NO. 2 AND WAIVER (this ?Amendment No. 2?), dated as of August 10, 2021 and entered into by and among Perrigo Finance Unlimited Company, a public unlimited company organized under the laws of Ireland (the ?Revolving Borrower?), Perrigo Company PLC, a public limited company organized under the laws of Ireland (the ?Company?), each lender party hereto (each a ?Consenting L

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of inco

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorp

Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 6, 2021 Perrigo Company plc (Exact name of registrant as specified in its charter) Commission file number 001-36353 Ireland Not Applicable (State or other jurisdiction of incorpo